Allergan
NICE thumbs up for Allergan’s Ozurdex
June 9, 2011Sales and Marketing Allergan, BRVO, CVRO, NICE, Ozurdex
In draft guidance NICE has recommended the use of Allergan’s eye treatment Ozurdex.NICE’s final decision on Ozurdex (dexamethasone) is expected …
Allergan marketing breaches discredited industry
March 22, 2011Medical Communications Allergan, Cephalon, PMCPA
Allergan, the manufacturer of Botox, has been censured for several breaches of the ABPI Code of Practice. The PMCPA watchdog …
European green light for Allergan’s Ozurdex
May 25, 2010Sales and Marketing Allergan, CHMP, Ozurdex, macular oedema
European authorities have given the green light for Ozurdex, a treatment for adults with a potentially serious eye disease. Ozurdex …
Allergan closes doors on Irish plant
May 8, 2009Manufacturing and Production Allergan
US drugmaker Allergan has brought the curtain down on its manufacturing facility in Arklow, Ireland, months ahead of schedule. The …
GSK linked to Allergan takeover
March 26, 2009Sales and Marketing Allergan, GSK
GlaxoSmithKline may be considering a bid to buy Allergan, the company behind 'cosmaceutical' products such as Botox. Analysts have seized …
Restylane TV campaign a first for ‘cosmaceuticals’
June 18, 2008Sales and Marketing Allergan, Eurocom, Restylane, disease awareness campaigns
The first European television adverts to promote a ‘cosmaceutical’ product have been broadcast in the UK.They feature Restylane, which is …
Allergan chooses UK for research base
June 16, 2006Allergan
US specialist pharmaceutical company Allergan has opened its new European research and development operations in Marlow in Buckinghamshire.Allergan is the …
Latest content
FibroFind appoints Lee Borthwick as CEO
